CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 19 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02391818
NCT02391818N/ACompleted
CompareCT.gov

The Effect of Taxane Chemotherapy on Balance in Breast Cancer Patients

OSF Healthcare System·observational·Posted Mar 18, 2015·Updated Aug 28, 2019

In Brief

An observational study for Distorted; Balance and 3 related conditions. Completed, enrolled 19 participants across 4 sites.

Detailed Summary

The purpose of this study is to quantify the balance impairments during and after taxane chemotherapy. Disability due to balance impairments caused by chemotherapy induced peripheral neuropathy (CIPN) can cause falls, injury, and a decline in independence. This results in poor treatment outcomes such as greater morbidity and mortality, inability to complete treatment protocols, self-limitation of activity, and diminished quality of life.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDistorted; Balance, Quality of Life, Neuropathy, Cancer
CountriesUnited States
CollaboratorsIllinois CancerCare, P.C., University of Illinois College of Medicine at Peoria, St. Francis Hospitals & Health Centers

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMar 18, 2015
Enrollment StartFeb 1, 2015
Primary CompletionJun 16, 2017
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 11.3 years ago